Literature DB >> 4018389

Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism.

D A Bender, G M McCreanor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4018389     DOI： 10.1042/bst0130441

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  22 in total

1.  Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke.

Authors:  Heidi Ormstad; Robert Verkerk; Hans Christian D Aass; Karl-Friedrich Amthor; Leiv Sandvik
Journal:  J Mol Neurosci       Date:  2013-08-30       Impact factor: 3.444

2.  Targeting inflammation to influence cognitive function following spinal cord injury: a randomized clinical trial.

Authors:  D J Allison; A R Josse; D A Gabriel; P Klentrou; D S Ditor
Journal:  Spinal Cord       Date:  2016-06-21       Impact factor: 2.772

3.  Quantification of the importance of individual steps in the control of aromatic amino acid metabolism.

Authors:  M Salter; R G Knowles; C I Pogson
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

Review 4.  Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.

Authors:  Ikwunga Wonodi; Robert Schwarcz
Journal:  Schizophr Bull       Date:  2010-02-10       Impact factor: 9.306

Review 5.  The role of the kynurenine metabolism in major depression.

Authors:  Aye-Mu Myint; Markus J Schwarz; Norbert Müller
Journal:  J Neural Transm (Vienna)       Date:  2011-12-03       Impact factor: 3.575

6.  A mathematical model of tryptophan metabolism via the kynurenine pathway provides insights into the effects of vitamin B-6 deficiency, tryptophan loading, and induction of tryptophan 2,3-dioxygenase on tryptophan metabolites.

Authors:  Luisa Rios-Avila; H Frederik Nijhout; Michael C Reed; Harry S Sitren; Jesse F Gregory
Journal:  J Nutr       Date:  2013-07-31       Impact factor: 4.798

7.  Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients.

Authors:  Daniela L Krause; Michael Riedel; Norbert Müller; Elif Weidinger; Markus J Schwarz; Aye-Mu Myint
Journal:  Inflammopharmacology       Date:  2012-01-12       Impact factor: 4.473

Review 8.  The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.

Authors:  María Isabel Cuartero; Juan de la Parra; Alicia García-Culebras; Iván Ballesteros; Ignacio Lizasoain; María Ángeles Moro
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 9.  IDO and TDO as a potential therapeutic target in different types of depression.

Authors:  Yanjie Qin; Nanxi Wang; Xinlin Zhang; Xuemei Han; Xuejia Zhai; Yongning Lu
Journal:  Metab Brain Dis       Date:  2018-07-16       Impact factor: 3.584

Review 10.  Neuropsychiatric disorders related to interferon and interleukins treatment.

Authors:  Aye Mu Myint; Markus J Schwarz; Harry W M Steinbusch; Brian E Leonard
Journal:  Metab Brain Dis       Date:  2008-12-10       Impact factor: 3.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.